Dept. of the Army -- USAMRAA
Focus areas
Funder intelligence
Based on active solicitations, USAMRAA continues a strong emphasis on disease-specific research, particularly Breast Cancer and Tuberous Sclerosis Complex, while maintaining a broad 'Peer Reviewed Medical' portfolio. There's a clear trend towards supporting translational and developmental research, including technology and therapeutic development, alongside foundational discovery. The inclusion of 'Lifestyle and Applied Health Research' also signals an interest in broader public health and preventive strategies.
Proposals typically undergo a two-tier review process: an initial scientific peer review for merit and feasibility, followed by a programmatic review that assesses relevance to the agency's mission and portfolio balance, often including consumer advocates.
Solicitations & opportunities (7)
- DoW Peer Reviewed Medical, Impact Award · due Aug 6, 2026
- DoW Alzheimer's Transforming Research Award · due Sep 24, 2026
- DoW Melanoma Research Program Melanoma Academy Scholar Award · due Oct 14, 2026
- DoW Melanoma Research Program Team Science Award · due Oct 14, 2026
- DoW Military Burn, Discovery Award · due Oct 21, 2026
- DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research · due Sep 30, 2027
- BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense · due Jul 31, 2028